cancer drug development
Media
GSK Makes Strategic $1.15 Billion Move to Acquire IDRx, Strengthening Its Cancer Treatment Portfolio
British pharmaceutical giant GSK has announced its agreement to acquire Boston-based biotechnology firm IDRx for up to $1.15 billion, marking a significant expansion...
Billionairesworld's billionaires
“Sun Piaoyang: Transforming China’s Pharmaceutical Industry and Building a Global Legacy”
Sun Piaoyang is the chairman of Jiangsu Hengrui Pharmaceuticals, one of China’s largest and most successful pharmaceutical companies. Under his leadership, the company...
